Eilon D. Kirson, Chief Science Officer at Novocure Ltd (NVCR), sold 44,388 shares at $22.01 ($977K) on 2017-11-01, disclosed to the SEC on 2017-11-02.
Open-market sale of $977k NVCR by Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.00 | 150 | $3K | 0.3% |
| 2 | $22.01 | 22,119 | $487K | 49.8% |
| 3 | $22.01 | 22,119 | $487K | 49.8% |
| Total | $22.01 avg | 44,388 | $977K | 100% |
| Filing → |
| NVCR | SELL | 2018-04-20 | $3.5M | — | Filing → |
| NVCR | SELL | 2018-01-16 | $557K | — | Filing → |
| NVCR | SELL | 2017-11-08 | $200K | — | Filing → |